1077BF is a randomized strategy trial, which is part of the PROMISE studies (1077BF, 1077FF, P1084s, and 1077HS). The Promoting...
The study is being done with people who are taking their first anti-HIV drug regimen (including an Non-Nucleoside Reverse...
The purpose of this study is to develop and assess the efficacy of an integrated strategy that includes feasible and scalable...
The A5322 protocol is a long-term observational study, with a planned series of analyses of data to be collected from an...
This study will enroll HIV-infected people who do not have evidence of active TB but who are at high risk of developing active...
